I dunno - her wording is curious.
"While only currently available in the United States, Acadia Pharmaceuticals in North America, and Neuron elsewhere in the world are perusing options to bring Trofinetide to other countries."
That could be interpreted in a few ways - Acadia looking at North America - Canada? Neu doing the rest of the world?
ROW Rights, page-63
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.33 |
Change
1.060(8.64%) |
Mkt cap ! $1.699B | |||
| Open | High | Low | Value | Volume |
| $12.95 | $13.39 | $12.79 | $8.494M | 648.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7 | $13.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.34 | 3490 | 12 |
View Market Depth
| Last trade - 15.46pm 06/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |